| Price | 80.00p on 19-11-2025 at 14:30:48 |
|---|---|
| Change | 0.00p 0% |
| Buy | 81.00p |
| Sell | 79.00p |
| Last Trade: | Sell 14,058.00 at 79.034p |
| Day's Volume: | 1,070,090 |
| Last Close: | 80.00p |
| Open: | 80.50p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 80.00p - 81.00p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £346.93m |
| VWAP: | 80.28696p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 14,058 | 79.034p | Ordinary |
14:30:32 - 19-Nov-25 |
| Sell* | 25,000 | 79.15p | Ordinary |
14:30:06 - 19-Nov-25 |
| Sell* | 1,992 | 79.00p | Ordinary |
14:26:04 - 19-Nov-25 |
| Sell* | 4,138 | 80.377p | Ordinary |
14:24:03 - 19-Nov-25 |
| Sell* | 10,000 | 80.20p | Ordinary |
14:22:51 - 19-Nov-25 |
| Sell* | 15 | 79.00p | Ordinary |
14:22:32 - 19-Nov-25 |
| Sell* | 10,711 | 80.20p | Ordinary |
14:19:39 - 19-Nov-25 |
| Sell* | 7,000 | 79.98p | Ordinary |
14:15:52 - 19-Nov-25 |
| Sell* | 400 | 79.00p | Ordinary |
14:11:40 - 19-Nov-25 |
| Sell* | 29,700 | 79.50p | Ordinary |
14:07:41 - 19-Nov-25 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
| 30th Sep 2025 7:00 am | RNS | Interim Half Year Results 2025 |
| 15th Sep 2025 7:00 am | RNS | Notice of Interim Results |
| 9th Sep 2025 7:00 am | RNS-R | Shortlisted for AIM Awards Technology of the Year |
